Cargando…
Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition
Type IIα DNA topoisomerase (TopoIIα) is among the most important clinical drug targets for the treatment of cancer. Recently, the DNA repair protein Metnase was shown to enhance TopoIIα activity and increase resistance to TopoIIα poisons. Using in vitro DNA decatenation assays we show that neoamphim...
Autores principales: | Ponder, Jessica, Yoo, Byong Hoon, Abraham, Adedoyin D., Li, Qun, Ashley, Amanda K., Amerin, Courtney L., Zhou, Qiong, Reid, Brian G., Reigan, Philip, Hromas, Robert, Nickoloff, Jac A., LaBarbera, Daniel V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229241/ https://www.ncbi.nlm.nih.gov/pubmed/22163192 http://dx.doi.org/10.3390/md9112397 |
Ejemplares similares
-
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
por: Li, Linfeng, et al.
Publicado: (2014) -
Metnase Mediates Resistance to Topoisomerase II Inhibitors in Breast Cancer Cells
por: Wray, Justin, et al.
Publicado: (2009) -
Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation
por: Shaheen, Montaser, et al.
Publicado: (2010) -
Metnase and EEPD1: DNA Repair Functions and Potential Targets in Cancer Therapy
por: Nickoloff, Jac A., et al.
Publicado: (2022) -
The DNA repair component Metnase regulates Chk1 stability
por: Williamson, Elizabeth A, et al.
Publicado: (2014)